PETA Science Consortium International e.V., Stuttgart, Germany.
European Commission, Joint Research Centre (JRC), Ispra, Italy.
Arch Toxicol. 2022 Nov;96(11):2865-2879. doi: 10.1007/s00204-022-03365-4. Epub 2022 Aug 20.
Robust and efficient processes are needed to establish scientific confidence in new approach methodologies (NAMs) if they are to be considered for regulatory applications. NAMs need to be fit for purpose, reliable and, for the assessment of human health effects, provide information relevant to human biology. They must also be independently reviewed and transparently communicated. Ideally, NAM developers should communicate with stakeholders such as regulators and industry to identify the question(s), and specified purpose that the NAM is intended to address, and the context in which it will be used. Assessment of the biological relevance of the NAM should focus on its alignment with human biology, mechanistic understanding, and ability to provide information that leads to health protective decisions, rather than solely comparing NAM-based chemical testing results with those from traditional animal test methods. However, when NAM results are compared to historical animal test results, the variability observed within animal test method results should be used to inform performance benchmarks. Building on previous efforts, this paper proposes a framework comprising five essential elements to establish scientific confidence in NAMs for regulatory use: fitness for purpose, human biological relevance, technical characterization, data integrity and transparency, and independent review. Universal uptake of this framework would facilitate the timely development and use of NAMs by the international community. While this paper focuses on NAMs for assessing human health effects of pesticides and industrial chemicals, many of the suggested elements are expected to apply to other types of chemicals and to ecotoxicological effect assessments.
如果要将新方法(NAMs)用于监管应用,就需要建立稳健且高效的流程来建立对其的科学信心。NAMs 需要具有针对性、可靠,并且对于人类健康影响的评估,需要提供与人类生物学相关的信息。此外,它们还必须经过独立审查并以透明的方式进行沟通。理想情况下,NAM 开发者应该与监管机构和行业等利益相关者进行沟通,以确定 NAM 旨在解决的问题和特定目的,以及它将被使用的背景。对 NAM 的生物学相关性的评估应侧重于其与人类生物学、机制理解的一致性,以及提供可导致健康保护决策的信息的能力,而不仅仅是将基于 NAM 的化学测试结果与传统动物测试方法的结果进行比较。然而,当将 NAM 结果与历史动物测试结果进行比较时,应利用动物测试方法结果内的可变性来告知性能基准。本文在先前努力的基础上,提出了一个包含五个必要要素的框架,以建立 NAMs 用于监管用途的科学信心:针对性、人类生物学相关性、技术特征、数据完整性和透明度以及独立审查。国际社会普遍采用这一框架将有助于及时开发和使用 NAMs。虽然本文侧重于用于评估农药和工业化学品对人类健康影响的 NAMs,但许多建议的要素预计将适用于其他类型的化学品和生态毒理学影响评估。